Morgan Stanley Sees May Same-Store Sales Uptick For Walgreen Company

In a report published Thursday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Overweight rating and $85.00 price target on

. In the report, Morgan Stanley noted, “Adjusted for calendar shift impact, May total same store sales were +5.7% vs. MS at +5.2%. This compares to a +3.1% comp in May ‘13 on an adjusted basis (which included y/y losses of ESRX customers), and a total sales comp of 5.5% for the combined March/April '14 period (which normalizes for shift in Easter timing this year).” Walgreen Company closed on Wednesday at $74.56.